Innovation: Nontoxic Antifungals that Target RNA

Innovation: RIG-I agonists as next-gen immunotherapies. (Co-Pitch with Akiko Iwasaki, PhD)

Innovation: Developing a proprietary class of molecules to be used as tumor vaccines. (Pilot Grant winner)

Anna Marie Pyle is the William Edward Gilbert Professor of Molecular, Cellular and Developmental Biology and Professor of Chemistry at Yale University. She has been a Howard Hughes Medical Institute Investigator since 1997. Dr. Pyle obtained her undergraduate degree in Chemistry from Princeton University and received her Ph.D. in Chemistry from Columbia University in 1990, where she worked with Professor Jacqueline K. Barton. Dr. Pyle was a postdoctoral fellow in the laboratory of Thomas Cech at the University of Colorado. Dr. Pyle formed her own research group in 1992 in the Department of Biochemistry and Molecular Biophysics at Columbia University Medical Center. In 2002, she moved to Yale University, where she leads a research group that specializes in structure and function of large RNA molecules and RNA remodeling enzymes. Dr. Pyle teaches the undergraduate Molecular Biology course at Yale and she is Chair of the Building Committee for the new Yale Biology Building. Dr. Pyle is the Chair of the MSFA Study Section at the NIH, and previously served as a permanent member on the MSFE, and MGB Study Sections. At Brookhaven National labs, she serves on the Science and Technology Steering Committee and on Beamline Advisory Teams at the NSLSII light source.